Ami Organics Limited

Equities

AMIORG

INE00FF01017

Diversified Chemicals

Market Closed - NSE India S.E. 07:42:29 2024-04-30 am EDT 5-day change 1st Jan Change
1,231 INR +0.20% Intraday chart for Ami Organics Limited +4.05% +9.70%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Ami Organics Limited announced that it expects to receive INR 990.99932 million in funding CI
Ami Organics Gets Board Nod to Raise Up To INR5 Billion Via QIP MT
Transcript : Ami Organics Limited, Q3 2024 Earnings Call, Feb 12, 2024
Ami Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Ami Organics Unit Begins Commercial Operations of Lithium-Ion Battery Cell Production MT
Ami Organics Signs MoU to Manufacture Battery Cell Electrolytes in Gujarat, India MT
Ami Organics to Manufacture Two APIs for Orion Subsidiary MT
Ami Organics Limited and Fermion Ink Another Agreement for Two Additional Advanced Pharmaceutical Intermediate with Fermion CI
Ami Organics Limited Unveils New Manufacturing Facility in Ankleshwar, Gujarat CI
CARE Gives A Rating to Ami Organics' Long-term Bank Financing; Outlook Stable MT
Transcript : Ami Organics Limited, Q2 2024 Earnings Call, Nov 09, 2023
Ami Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Ami Organics Limited announced that it has received INR 518.4515 million in funding CI
Ami Organics to Supply Advanced Pharmaceutical Intermediates to Unit of Finland-based Orion MT
Ami Organics Limited Signs Definitive Multi-Year Multi-Tonne Agreement with Fermion CI
Ami Organics Forms New Wholly Owned Arm MT
Ami Organics Limited Announces Incorporation of Wholly Owned Subsidiary CI
INDIA STOCKS-Financials, IT lead rise in Indian shares as U.S. rate concerns ease RE
Indian shares set to open higher on easing US rate concerns RE
Transcript : Ami Organics Limited, Q1 2024 Earnings Call, Aug 11, 2023
Ami Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Ami Organics Limited Approves Incorporation of the Wholly Owned Subsidiary Company CI
Ami Organics Limited Announces Appointment of Mr. Nareshkumar R. Patel as Member and Chairman of the Risk Management Committee CI
Transcript : Ami Organics Limited, Q4 2023 Earnings Call, May 15, 2023
Ami Organics Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Chart Ami Organics Limited
More charts
Ami Organics Limited is an India-based manufacturer of specialty chemicals with varied end usage, focus on the development and manufacturing of pharma intermediates for regulated and generic active pharmaceutical ingredient (APIs) and new chemical entity (NCEs). It manufactures pharma intermediates for certain APIs, including dolutegravir, trazodone, entacapone, nintedanib and rivaroxaban. The pharma intermediates, which the Company manufactures have application in certain high-growth therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant. It has developed and commercialized over 450 pharma intermediates for APIs and NCEs across 17 therapeutic areas. Its specialty chemicals have applications in the agrochemicals and fine chemicals industries. The Company supplies its products to more than 150 customers directly in India and to approximately 25 countries overseas.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,231 INR
Average target price
1,331 INR
Spread / Average Target
+8.16%
Consensus
  1. Stock Market
  2. Equities
  3. AMIORG Stock
  4. News Ami Organics Limited
  5. Ami Organics to Supply Advanced Pharmaceutical Intermediates to Unit of Finland-based Orion